PR Newswire Asia's news > Medical/Pharmaceuticals

 < Previous page   |   Detail   |   Print    Next page > 
     
Laminar Pharma Announces "Last Patient, Last Visit" in LAM561 Phase 2b/3 Trial for Newly Diagnosed Glioblastoma Patients
2026-07-24T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
ArkBio Completes all Cohort Dosing in Australian Phase I Trial with Influenza AFC Drug AK0406
2026-07-24T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Harbour BioMed Announces Positive Profit Alert for 2026 Interim Results, Marking Seventh Consecutive Profitable Half-Year as Platform-Based Advantages Drive Sustainable Growth
2026-07-24T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Fapon Showcases AI-Engineered Enzymes and Alzheimer's Solutions at ADLM 2026, Reinforcing North American Commitment
2026-07-24T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
AH-008 Achieves Key Clinical Milestone with Successful First Subject First Dose (FSFD) in Phase I Study for Prevention of Chemotherapy-Induced Peripheral Neuropathy (CIPN)
2026-07-23T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Zhongchao Inc. Announces $5.0 Million Registered Direct Offering
2026-07-23T    Computer/Electronics   Health Care/Hospital   Medical/Pharmaceuticals 
Haisco's Class 1 Innovative Drug Ciprocopan Succinate Tablets Approved in China, Offering a New Treatment Option for Patients With PNH
2026-07-23T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Nona Biosciences Enters Research Collaboration with the Medical University of Vienna to Advance Fully Human Antibody Development for Infectious Diseases
2026-07-23T    Biotechnology   Higher Education   Medical/Pharmaceuticals 
Ascletis Announces Oral Discussion of ASC36_35 FDC Preclinical Data Demonstrating Superior Weight Loss to Eloralintide/Tirzepatide Combination at the 62nd European Association for the Study of Diabetes (EASD) Annual Meeting
2026-07-23T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Samsung Biologics Reports Second Quarter 2026 Financial Results
2026-07-23T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
 < Previous page    Next page >

 

88iv | Home |  Login
Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer
Copyright (C) 2026
Suntek Computer Systems Limited.
All rights reserved